CEO Q&A with Neil Crabb at Frontier IP Group Plc (LON:FIPP)

Frontier IP Group Plc (LON:FIPP) Chief Executive Officer Neil Crabb caught up with DirectorsTalk for an exclusive interview to discuss the launch of Molendotech bathing water test

 

Q1: First off, can I just ask what Molendotech is & what was announced?

A1: Molendotech is a spin-out we set up under a year ago from Plymouth University & it’s focussed on detecting faecal bacteria in water.

So, if you think about where you swim or later when you’re drinking or food you might eat, obviously it’s coming into contact with water& if that water is contaminated, there’s a risk you become ill. Centrally, the technology from the Palintest, from the team at Plymouth, is around being able to check that much more quickly than is currently done.

 

Q2: Why is the announcement important to Frontier IP?

A2: Well, we have a very strong emphasise on trying to drive industry adoption of technology so that we can get it rapidly deployed within the market & Palintest, who are our partner in this, are part of Halma plc (LON:HLMA), the FTSE 100 company who are global leaders in water testing.

So, we got them to look at the potential & they feel it has a really strong place in the market but clearly, they are much better at delivering that than a university spin-out would be going directly itself to try & sell to local authorities or whoever the customer might be.

So, it’s really, from our point of view, strong validation of our model that if you engage in the right way, you can get early industry adoption, in this case it’s been less than a year from creating the spin-out to getting a FTSE 100 company actually launching the test commercially on the market.

 

Q3: What else is in Frontier IP Group’s portfolio then?

A3: So, we’ve got a broad spread, really reflective of the wide range of research that we find in the universities that we’re working with.

If we look across, some of the highlights I would draw attention is something called Nandi Proteins, which is allowing protein to be used to reduce the sugar, fat and additives that are commonly found in processed food. They are already working with, for example, Devro plc (LON:DVO), a FTSE 250 company & a number of other major food groups where there’s strong pressure on the food industry to essentially make healthier processed foods. We’ve already seen that in the drinks arena with the sugar tax & the same pressures exist within the food market so they’re helping to address that.

Looking at Plymouth specifically, we’ve got another spin out called Fieldwork Robotics which is, as the name might suggest, developing robots that are specifically for use in agriculture, that’s for picking soft fruit and vegetables, & there has been a lot of industry interest in that as well. There is ongoing pressure to reduce the labour component within agriculture & this technology can play a part in helping that both in the UK & abroad.

We’ve got another company, Alusid, which is a spin-out from the University of Central Lancashire, & that’s taking waste form the porcelain and glass industry and turning it into novel building materials & it does that in a very economic fashion So, we’ve already seen strong interest in a range of customers there that have been adopting that technology which is encouraging.

Final one I would draw attention to is Tarsis Technology, out of Cambridge, & that’s taking a different type of novel material, metal-organic frameworks. It basically allows you to create a porous matrix in which you can lock particles to allow them to be delivered in a much more controlled way than is currently done. So, a broad spectrum.

Click to view all articles for the EPIC: , ,
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018,

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence

    Frontier IP Group Plc

    Rallybio forges joint venture with U.K. tech firm

    A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom. Rallybio, focused on rare diseases, has not yet publicly

    Frontier IP Group Plc

    What is leptospirosis and how can it harm us and our pets?

    Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans. This zoonotic disease is spread by rats and other rodents. However, this

    Frontier IP Group Plc

    The Robot Uprising Is Here

    The robot uprising is inevitable. Take the world’s first raspberry-picking robot, an autonomous machine that’s in development by Fieldwork Robotics at the University of Plymouth in the UK. This fruit-picking Terminator, so to speak, was developed for

    Frontier IP Group Plc

    The UK’s 50 Most Disruptive Companies Revealed

    After receiving applications from a wide range of early stage and more established companies from across industries, the initial list was whittled down to 100 by D/SRUPTION. The list was then submitted to an expert judging

    Frontier IP Group Plc

    Artificial intelligence in the world of drug discovery

    Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the

    Frontier IP Group Plc

    11 diseases which can cause infection

    Illnesses that can pass from animals to humans are known as zoonotic. They’re surprisingly common: More than six out of every 10 known infectious diseases in people are actually contracted from animals, according to the CDC.